Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Carillon

Carillon Eagle Small Cap Growth Fund Class A (HRSCX)

Ticker HRSCX · Since 1993-05-07 · · Holdings as of Jun 30, 2026

Expense ratio
1.18%$118/yr per $10k
5-yr return
+0.2%annualized
1-yr return
+6.0%as of Dec 2025
Net assets
$498.1Mall share classes
Holdings
108

Bottom line

Is HRSCX a good fund? The bottom line

HRSCX is the Class A share class of Carillon Eagle Small Cap Growth Fund, an actively managed small-cap mutual fund from Carillon.

Its expense ratio is 1.18% — about $118 a year on every $10,000 invested, more expensive than 68% of small-cap funds we track.

It returned +6.0% over one year, +0.2% a year over five years, +7.7% a year over ten (as of Dec 31, 2025, per its prospectus).

With $498 million in net assets and 108 holdings, its largest position is BrightSpring Health Services I (2.6%) and the top 10 make up 19.1% of the portfolio.

This share class carries a front-end sales charge of up to 4.75%; a no-load class or ETF alternative can avoid it.

What to watch

  • 5-year return in the bottom quarter of its category
  • Front-end sales load up to 4.75%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What HRSCX invests in

The Carillon Eagle Small Cap Growth Fund (Eagle Small Cap Growth Fund or the fund) seeks long-term capital appreciation.

During normal market conditions, the Eagle Small Cap Growth Fund seeks to achieve its objective by investing at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in the stocks of small-capitalization companies. The funds portfolio managers consider small-capitalization companies to be those companies that, at the time of initial purchase, have a market capitalization equal to or less than the largest company in the Russell 2000 Growth Index during the most recent 12-month period (approximately $32.4 billion during the 12-month period ended December 31, 2025). The fund is not required to sell equity securities whose market values appreciate or depreciate outside this market capitalization range. When making their investment decisions, the portfolio managers generally focus on investing in the dividend paying equity securities, generally common…

From the fund's prospectus (filed Apr 28, 2026).

HRSCX performance

Average annual total returns
1 yr5 yr10 yr
HRSCX+6.0%+0.2%+7.7%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full HRSCX performance history →

What HRSCX costs

On a $10,000 investment, HRSCX's 1.18% expense ratio costs about $118 a year. The prospectus estimates $1,839 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full HRSCX fee table →

HRSCX top 10 holdings

#Holding% of fund
1BrightSpring Health Services I BTSG2.64%
2First American Government Obli2.25%
3Dycom Industries Inc DY2.19%
4Archrock Inc AROC1.95%
5Solstice Advanced Materials In SOLS1.77%
6RB Global Inc RBA1.70%
7PJT Partners Inc PJT1.69%
8Mercury Systems Inc MRCY1.66%
9SiTime Corp SITM1.63%
10Littelfuse Inc LFUS1.61%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 19.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to HRSCX

More funds like HRSCX →

HRSCX FAQ

What is the expense ratio of HRSCX?
HRSCX's expense ratio is 1.18%, which works out to about $118 a year for every $10,000 invested. The prospectus estimates total costs of $1,839 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is HRSCX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category; front-end sales load up to 4.75%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does HRSCX hold?
HRSCX's largest holdings are BrightSpring Health Services I (2.6%), First American Government Obli (2.3%), Dycom Industries Inc (2.2%), Archrock Inc (2.0%), Solstice Advanced Materials In (1.8%). It holds 108 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is HRSCX's 5-year return?
HRSCX returned +0.2% a year over the five years ending Dec 31, 2025, and +7.7% a year over ten years. Past performance does not guarantee future results.
Does HRSCX have a sales load?
Yes. HRSCX has a maximum front-end sales charge of 4.75%.
Who manages HRSCX?
HRSCX is offered by Carillon through Carillon Series Trust.